Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel Free MIG5 Stock Alerts

Maven Income and Growth VCT 5 (MIG5) Competitors

Maven Income and Growth VCT 5 logo
GBX 27.80 -1.00 (-3.47%)
As of 05:16 AM Eastern
Compare

MIG5 vs. BGS, CVCG, BRFI, PCFC, and IBT

Should you buy Maven Income and Growth VCT 5 stock or one of its competitors? MarketBeat compares Maven Income and Growth VCT 5 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Maven Income and Growth VCT 5 include Baillie Gifford Shin Nippon (BGS), CVC Income & Growth GBP (CVCG), BlackRock Frontiers (BRFI), Polar Capital Global Financials Trust (PCFC), and International Biotechnology (IBT). These companies are all part of the "asset management" industry.

How does Maven Income and Growth VCT 5 compare to Baillie Gifford Shin Nippon?

Baillie Gifford Shin Nippon (LON:BGS) and Maven Income and Growth VCT 5 (LON:MIG5) are both small-cap financial services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

Baillie Gifford Shin Nippon has a beta of 0.91967845, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Maven Income and Growth VCT 5 has a beta of 0.13, meaning that its stock price is 87% less volatile than the broader market.

Baillie Gifford Shin Nippon pays an annual dividend of GBX 0.60 per share and has a dividend yield of 0.4%. Maven Income and Growth VCT 5 pays an annual dividend of GBX 2.25 per share and has a dividend yield of 8.1%. Baillie Gifford Shin Nippon pays out 12.0% of its earnings in the form of a dividend. Maven Income and Growth VCT 5 pays out 271.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Maven Income and Growth VCT 5's average media sentiment score of 0.84 beat Baillie Gifford Shin Nippon's score of 0.00 indicating that Maven Income and Growth VCT 5 is being referred to more favorably in the news media.

Company Overall Sentiment
Baillie Gifford Shin Nippon Neutral
Maven Income and Growth VCT 5 Positive

14.0% of Baillie Gifford Shin Nippon shares are owned by institutional investors. 0.2% of Baillie Gifford Shin Nippon shares are owned by insiders. Comparatively, 0.6% of Maven Income and Growth VCT 5 shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Baillie Gifford Shin Nippon has a net margin of 101.98% compared to Maven Income and Growth VCT 5's net margin of 52.62%. Baillie Gifford Shin Nippon's return on equity of 3.55% beat Maven Income and Growth VCT 5's return on equity.

Company Net Margins Return on Equity Return on Assets
Baillie Gifford Shin Nippon101.98% 3.55% -7.19%
Maven Income and Growth VCT 5 52.62%2.61%-3.05%

Maven Income and Growth VCT 5 has lower revenue, but higher earnings than Baillie Gifford Shin Nippon. Baillie Gifford Shin Nippon is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 5, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baillie Gifford Shin Nippon£14.48M22.14-£55.32M£4.9932.10
Maven Income and Growth VCT 5£2.34M31.79-£354.47K£0.8333.49

Summary

Baillie Gifford Shin Nippon and Maven Income and Growth VCT 5 tied by winning 7 of the 14 factors compared between the two stocks.

How does Maven Income and Growth VCT 5 compare to CVC Income & Growth GBP?

CVC Income & Growth GBP (LON:CVCG) and Maven Income and Growth VCT 5 (LON:MIG5) are both small-cap financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Maven Income and Growth VCT 5 has a net margin of 52.62% compared to CVC Income & Growth GBP's net margin of -20.08%. Maven Income and Growth VCT 5's return on equity of 2.61% beat CVC Income & Growth GBP's return on equity.

Company Net Margins Return on Equity Return on Assets
CVC Income & Growth GBP-20.08% -1.99% N/A
Maven Income and Growth VCT 5 52.62%2.61%-3.05%

CVC Income & Growth GBP has higher revenue and earnings than Maven Income and Growth VCT 5. CVC Income & Growth GBP is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 5, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVC Income & Growth GBP£18.73M16.92£366.88M-£4.94N/A
Maven Income and Growth VCT 5£2.34M31.79-£354.47K£0.8333.49

CVC Income & Growth GBP has a beta of 0.19298494, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, Maven Income and Growth VCT 5 has a beta of 0.13, suggesting that its stock price is 87% less volatile than the broader market.

7.8% of CVC Income & Growth GBP shares are held by institutional investors. 0.1% of CVC Income & Growth GBP shares are held by insiders. Comparatively, 0.6% of Maven Income and Growth VCT 5 shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CVC Income & Growth GBP pays an annual dividend of GBX 12 per share and has a dividend yield of 10.5%. Maven Income and Growth VCT 5 pays an annual dividend of GBX 2.25 per share and has a dividend yield of 8.1%. CVC Income & Growth GBP pays out -243.0% of its earnings in the form of a dividend. Maven Income and Growth VCT 5 pays out 271.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. CVC Income & Growth GBP is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Maven Income and Growth VCT 5's average media sentiment score of 0.84 beat CVC Income & Growth GBP's score of 0.00 indicating that Maven Income and Growth VCT 5 is being referred to more favorably in the news media.

Company Overall Sentiment
CVC Income & Growth GBP Neutral
Maven Income and Growth VCT 5 Positive

Summary

CVC Income & Growth GBP and Maven Income and Growth VCT 5 tied by winning 7 of the 14 factors compared between the two stocks.

How does Maven Income and Growth VCT 5 compare to BlackRock Frontiers?

BlackRock Frontiers (LON:BRFI) and Maven Income and Growth VCT 5 (LON:MIG5) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

In the previous week, Maven Income and Growth VCT 5's average media sentiment score of 0.84 beat BlackRock Frontiers' score of 0.00 indicating that Maven Income and Growth VCT 5 is being referred to more favorably in the news media.

Company Overall Sentiment
BlackRock Frontiers Neutral
Maven Income and Growth VCT 5 Positive

8.4% of BlackRock Frontiers shares are owned by institutional investors. 0.4% of BlackRock Frontiers shares are owned by company insiders. Comparatively, 0.6% of Maven Income and Growth VCT 5 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

BlackRock Frontiers pays an annual dividend of GBX 9.61 per share and has a dividend yield of 5.1%. Maven Income and Growth VCT 5 pays an annual dividend of GBX 2.25 per share and has a dividend yield of 8.1%. BlackRock Frontiers pays out 30.9% of its earnings in the form of a dividend. Maven Income and Growth VCT 5 pays out 271.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

BlackRock Frontiers has a net margin of 159.60% compared to Maven Income and Growth VCT 5's net margin of 52.62%. BlackRock Frontiers' return on equity of 10.70% beat Maven Income and Growth VCT 5's return on equity.

Company Net Margins Return on Equity Return on Assets
BlackRock Frontiers159.60% 10.70% 13.46%
Maven Income and Growth VCT 5 52.62%2.61%-3.05%

BlackRock Frontiers has higher revenue and earnings than Maven Income and Growth VCT 5. BlackRock Frontiers is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 5, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Frontiers£62.09M4.99£73.42M£31.106.08
Maven Income and Growth VCT 5£2.34M31.79-£354.47K£0.8333.49

BlackRock Frontiers has a beta of 0.83049625, indicating that its share price is 17% less volatile than the broader market. Comparatively, Maven Income and Growth VCT 5 has a beta of 0.13, indicating that its share price is 87% less volatile than the broader market.

Summary

BlackRock Frontiers beats Maven Income and Growth VCT 5 on 9 of the 14 factors compared between the two stocks.

How does Maven Income and Growth VCT 5 compare to Polar Capital Global Financials Trust?

Maven Income and Growth VCT 5 (LON:MIG5) and Polar Capital Global Financials Trust (LON:PCFC) are both small-cap asset management industry companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

In the previous week, Maven Income and Growth VCT 5's average media sentiment score of 0.84 beat Polar Capital Global Financials Trust's score of 0.00 indicating that Maven Income and Growth VCT 5 is being referred to more favorably in the media.

Company Overall Sentiment
Maven Income and Growth VCT 5 Positive
Polar Capital Global Financials Trust Neutral

Polar Capital Global Financials Trust has higher revenue and earnings than Maven Income and Growth VCT 5. Polar Capital Global Financials Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 5, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 5£2.34M31.79-£354.47K£0.8333.49
Polar Capital Global Financials Trust£70.33M0.00N/A£49.50N/A

Maven Income and Growth VCT 5 has a net margin of 52.62% compared to Polar Capital Global Financials Trust's net margin of 0.00%. Maven Income and Growth VCT 5's return on equity of 2.61% beat Polar Capital Global Financials Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 552.62% 2.61% -3.05%
Polar Capital Global Financials Trust N/A N/A N/A

Summary

Maven Income and Growth VCT 5 beats Polar Capital Global Financials Trust on 4 of the 7 factors compared between the two stocks.

How does Maven Income and Growth VCT 5 compare to International Biotechnology?

Maven Income and Growth VCT 5 (LON:MIG5) and International Biotechnology (LON:IBT) are both small-cap financial services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

In the previous week, Maven Income and Growth VCT 5's average media sentiment score of 0.84 beat International Biotechnology's score of 0.00 indicating that Maven Income and Growth VCT 5 is being referred to more favorably in the media.

Company Overall Sentiment
Maven Income and Growth VCT 5 Positive
International Biotechnology Neutral

Maven Income and Growth VCT 5 pays an annual dividend of GBX 2.25 per share and has a dividend yield of 8.1%. International Biotechnology pays an annual dividend of GBX 31.73 per share and has a dividend yield of 3.2%. Maven Income and Growth VCT 5 pays out 271.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. International Biotechnology pays out -964.4% of its earnings in the form of a dividend.

International Biotechnology has lower revenue, but higher earnings than Maven Income and Growth VCT 5. International Biotechnology is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 5, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 5£2.34M31.79-£354.47K£0.8333.49
International Biotechnology-£175K-1,804.19£37.91M-£3.29N/A

International Biotechnology has a net margin of 82.27% compared to Maven Income and Growth VCT 5's net margin of 52.62%. International Biotechnology's return on equity of 27.35% beat Maven Income and Growth VCT 5's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 552.62% 2.61% -3.05%
International Biotechnology 82.27%27.35%3.57%

Maven Income and Growth VCT 5 has a beta of 0.13, meaning that its share price is 87% less volatile than the broader market. Comparatively, International Biotechnology has a beta of 0.316, meaning that its share price is 68% less volatile than the broader market.

6.9% of International Biotechnology shares are held by institutional investors. 0.6% of Maven Income and Growth VCT 5 shares are held by company insiders. Comparatively, 1.1% of International Biotechnology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

International Biotechnology beats Maven Income and Growth VCT 5 on 8 of the 14 factors compared between the two stocks.

Get Maven Income and Growth VCT 5 News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIG5 and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MIG5 vs. The Competition

Export
MetricMaven Income and Growth VCT 5Asset Management IndustryFinancial SectorLON Exchange
Market Cap£74.33M£2.40B£5.89B£2.82B
Dividend Yield7.12%5.94%5.21%6.08%
P/E Ratio33.4925.3315.88365.95
Price / Sales31.792,025.801,029.2088,165.73
Price / Cash2.3960.1592.5627.89
Price / Book0.831.386.577.71
Net Income-£354.47K£265.53M£1.14B£5.89B
7 Day Performance-6.71%1.20%0.85%1.78%
1 Month PerformanceN/A2.48%2.32%3.80%
1 Year PerformanceN/A13.17%19.75%70.49%

Maven Income and Growth VCT 5 Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MIG5
Maven Income and Growth VCT 5
N/AGBX 27.80
-3.5%		N/AN/A£74.33M£2.34M33.49N/A
BGS
Baillie Gifford Shin Nippon
N/AGBX 158.40
+1.1%		N/A+43.5%£316.90M£14.48M31.743,080
CVCG
CVC Income & Growth GBP
N/AGBX 114.29
-0.2%		N/A-2.3%£316.38M£18.73MN/AN/A
BRFI
BlackRock Frontiers
N/AGBX 192.50
+2.9%		N/A+22.4%£315.88M£62.09M6.19N/A
PCFC
Polar Capital Global Financials Trust
N/AN/AN/AN/A£315.13M£70.33M2.09N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:MIG5) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
The AI stocks about to become worthless (and one that isn't)
Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...
InvestorPlace | Sponsoredtc pixel